Abstract: A micro strip to waveguide transition includes a waveguide module and a section of printed circuit board (PCB). The waveguide module includes a waveguide aperture and a repetitive structure. The waveguide aperture is arranged extending through the module for attaching a waveguide to an external side of the module. The repetitive structure includes a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side. The repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage. The transition further includes a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.

Abstract: A micro strip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.

Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

Abstract: A micro strip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.

Abstract: An antenna arrangement having a stacked layered structure. The antenna arrangement includes a radiation layer including one or more radiation elements, and a distribution layer facing the radiation layer. The distribution layer is arranged to distribute a radio frequency signal to the one or more radiation elements. The distribution layer includes at least one distribution layer feed and a first electromagnetic bandgap, EBG, structure arranged to form at least one first waveguide intermediate the distribution layer and the radiation layer. The first EBG structure is also arranged to prevent electromagnetic propagation in a frequency band of operation from propagating from the at least one first waveguide in directions other than through the at least one distribution layer feed and the one or more radiation elements. The distribution layer includes a plurality of distribution modules and a positioning structure, the positioning structure is arranged to fix the distribution modules in position.

Abstract: A microstrip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.

Abstract: An antenna arrangement having a stacked layered structure. The antenna arrangement includes a radiation layer including one or more radiation elements, and a distribution layer facing the radiation layer. The distribution layer is arranged to distribute a radio frequency signal to the one or more radiation elements. The distribution layer includes at least one distribution layer feed and a first electromagnetic bandgap, EBG, structure arranged to form at least one first waveguide intermediate the distribution layer and the radiation layer. The first EBG structure is also arranged to prevent electromagnetic propagation in a frequency band of operation from propagating from the at least one first waveguide in directions other than through the at least one distribution layer feed and the one or more radiation elements. The distribution layer includes a plurality of distribution modules and a positioning structure, the positioning structure is arranged to fix the distribution modules in position.

Abstract: A medicament delivery device comprising: a first component, and a second component arranged concentrically with the first component, wherein the second component is configured to move axially relative to the first component from a first position to a second position, wherein one of the first component and the second component has a radially extending flash, wherein the other one of the first component and the second component has a chamfer aligned with and facing the flash when the second component is in the first position, and wherein one of the chamfer and the flash is configured to contact and subsequently pass the other one of the chamfer and the flash when the second component is moved from the first position towards the second position to thereby facilitate movement of the second component.

Abstract: A microstrip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.

Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

Abstract: A communication device for mounting to an infrastructure, the communication device being configured for communication with a remote communication device via a directive antenna main lobe, the communication device comprising a sensor module configured to measure a movement of the communication device relative to a reference orientation.

Abstract: A communication device for mounting to an infrastructure, the communication device being configured for communication with a remote communication device via a directive antenna main lobe, the communication device comprising a sensor module configured to measure a movement of the communication device relative to a reference orientation.

Abstract: Phenyl triazole derivative (specifically, 1-[6-[[5-(2-fluorophenyl)-3-methyl-triazol-4-yl]methoxy]-3-pyridyl]imidazole-4-carbonitrile or a pharmaceutically acceptable salt thereof), pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.

Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.

Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.

Abstract: A system for defining motions of a plurality of real robots cooperatively performing a show based on a description of the motions of the robots defined by animation software. The system includes at least one storage for storing a plurality of segments that describe the motions of the robots during the show, each segment includes a description of motions of one of the robots during a defined time period, and for storing a plurality of scenes, each scene specifying a plurality of segments to be executed simultaneously by the robots, and a playlist handler configured to handle creation of a playlist including a sequence of scenes and to amend the playlist according to user commands, and a user interface configured to display the playlist to a user, to allow the user to edit the playlist by amending the sequence of scenes, and to receive the user commands.

Abstract: Provided is a medicament delivery device comprising an axially elongated housing, a coaxially extending plunger rod mounted with in the housing for expelling successive doses of medicament and rotateable about the axis. The plunger rod can be axially displaced from a ready-to-use position for expelling a dose of medicament to a non-ready-to-use position axially spaced from said ready-to-use position along the axis, and from said non-ready-to use position to a subsequent ready-to-use position angularly spaced from said non-ready-to use position about the axis The device further comprises an indicator member displaceably mounted onto the housing between a first angular position indicative of the ready-to-use positions and a second angular position indicative of the non-ready-to use positions.

Abstract: A system for defining motions of a plurality of real robots cooperatively performing a show based on a description of the motions of the robots defined by animation software. The system includes at least one storage for storing a plurality of segments that describe the motions of the robots during the show, each segment includes a description of motions of one of the robots during a defined time period, and for storing a plurality of scenes, each scene specifying a plurality of segments to be executed simultaneously by the robots, and a playlist handler configured to handle creation of a playlist including a sequence of scenes and to amend the playlist according to user commands, and a user interface configured to display the playlist to a user, to allow the user to edit the playlist by amending the sequence of scenes, and to receive the user commands.

Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.